BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Ning J, Chen L, Rietjens IM. Role of toxicokinetics and alternative testing strategies in pyrrolizidine alkaloid toxicity and risk assessment; state-of-the-art and future perspectives. Food and Chemical Toxicology 2019;131:110572. [DOI: 10.1016/j.fct.2019.110572] [Cited by in Crossref: 11] [Cited by in F6Publishing: 9] [Article Influence: 3.7] [Reference Citation Analysis]
Number Citing Articles
1 Fragki S, Piersma AH, Westerhout J, Kienhuis A, Kramer NI, Zeilmaker MJ. Applicability of generic PBK modelling in chemical hazard assessment: A case study with IndusChemFate. Regulatory Toxicology and Pharmacology 2022;136:105267. [DOI: 10.1016/j.yrtph.2022.105267] [Reference Citation Analysis]
2 Chang X, Tan Y, Allen DG, Bell S, Brown PC, Browning L, Ceger P, Gearhart J, Hakkinen PJ, Kabadi SV, Kleinstreuer NC, Lumen A, Matheson J, Paini A, Pangburn HA, Petersen EJ, Reinke EN, Ribeiro AJS, Sipes N, Sweeney LM, Wambaugh JF, Wange R, Wetmore BA, Mumtaz M. IVIVE: Facilitating the Use of In Vitro Toxicity Data in Risk Assessment and Decision Making. Toxics 2022;10:232. [DOI: 10.3390/toxics10050232] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
3 Ren Z, Zhang H, Wang Z, Chen X, Yang L, Jiang H. Progress in Immunoassays of Toxic Alkaloids in Plant-Derived Medicines: A Review. Toxins 2022;14:165. [DOI: 10.3390/toxins14030165] [Reference Citation Analysis]
4 Mak KK, Epemolu O, Pichika MR. The role of DMPK science in improving pharmaceutical research and development efficiency. Drug Discov Today 2021:S1359-6446(21)00484-0. [PMID: 34774767 DOI: 10.1016/j.drudis.2021.11.005] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
5 Schrenk D, Fahrer J, Allemang A, Fu P, Lin G, Mahony C, Mulder PPJ, Peijnenburg A, Pfuhler S, Rietjens IMCM, Sachse B, Steinhoff B, These A, Troutman J, Wiesner J. Novel Insights into Pyrrolizidine Alkaloid Toxicity and Implications for Risk Assessment: Occurrence, Genotoxicity, Toxicokinetics, Risk Assessment-A Workshop Report. Planta Med 2021. [PMID: 34715696 DOI: 10.1055/a-1646-3618] [Reference Citation Analysis]
6 M Pauzi NA, Cheema MS, Ismail A, Ghazali AR, Abdullah R. Safety assessment of natural products in Malaysia: current practices, challenges, and new strategies. Rev Environ Health 2021. [PMID: 34582637 DOI: 10.1515/reveh-2021-0072] [Reference Citation Analysis]
7 Zhu Q, Jia Y, Guo J, Meng X, Chong L, Xu L, Zhou L, Sun Z. Establishment of an in vitro method of rabbit embryo toxicity with toxicokinetics study. J Appl Toxicol 2021. [PMID: 34322893 DOI: 10.1002/jat.4223] [Reference Citation Analysis]
8 Giera DS, Preisitsch M, Brevard H, Nemetz J. Quantitative Removal of Pyrrolizidine Alkaloids from Essential Oils by the Hydrodistillation Step in Their Manufacturing Process. Planta Med 2021. [PMID: 34293805 DOI: 10.1055/a-1534-6928] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Wiesner J. Regulatory Perspectives of Pyrrolizidine Alkaloid Contamination in Herbal Medicinal Products. Planta Med 2021. [PMID: 34169489 DOI: 10.1055/a-1494-1363] [Cited by in Crossref: 6] [Cited by in F6Publishing: 4] [Article Influence: 6.0] [Reference Citation Analysis]
10 Osman AG, Ali Z, Chittiboyina AG, Khan IA. An update on plant toxins posing human health risks. Foodborne Infections and Intoxications 2021. [DOI: 10.1016/b978-0-12-819519-2.00022-0] [Reference Citation Analysis]
11 Geburek I, Schrenk D, These A. In vitro biotransformation of pyrrolizidine alkaloids in different species: part II-identification and quantitative assessment of the metabolite profile of six structurally different pyrrolizidine alkaloids. Arch Toxicol 2020;94:3759-74. [PMID: 32880719 DOI: 10.1007/s00204-020-02853-9] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
12 Liu R, Li X, Huang N, Fan M, Sun R. Toxicity of traditional Chinese medicine herbal and mineral products. Adv Pharmacol 2020;87:301-46. [PMID: 32089237 DOI: 10.1016/bs.apha.2019.08.001] [Cited by in Crossref: 24] [Cited by in F6Publishing: 5] [Article Influence: 8.0] [Reference Citation Analysis]